View ValuationEMS-CHEMIE HOLDING 향후 성장Future 기준 점검 2/6EMS-CHEMIE HOLDING (는) 각각 연간 5% 및 2.7% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 4.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 27.2% 로 예상됩니다.핵심 정보5.0%이익 성장률4.61%EPS 성장률Chemicals 이익 성장8.3%매출 성장률2.7%향후 자기자본이익률27.16%애널리스트 커버리지Good마지막 업데이트19 Jun 2026최근 향후 성장 업데이트Price Target Changed • Jul 16Price target increased by 8.2% to CHF731Up from CHF675, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CHF708. Stock is up 2.6% over the past year. The company is forecast to post earnings per share of CHF20.29 for next year compared to CHF19.56 last year.Price Target Changed • Oct 31Price target decreased to CHF757Down from CHF849, the current price target is an average from 7 analysts. New target price is 20% above last closing price of CHF630. Stock is down 31% over the past year. The company is forecast to post earnings per share of CHF23.96 for next year compared to CHF23.53 last year.Price Target Changed • Oct 26Price target decreased to CHF826Down from CHF902, the current price target is an average from 7 analysts. New target price is 24% above last closing price of CHF665. Stock is down 29% over the past year. The company is forecast to post earnings per share of CHF24.02 for next year compared to CHF23.53 last year.Price Target Changed • Jul 26Price target increased to CHF936Up from CHF844, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of CHF966. Stock is up 21% over the past year.Price Target Changed • Apr 24Price target increased to CHF801Up from CHF712, the current price target is an average from 5 analysts. New target price is 9.3% below last closing price of CHF883. Stock is up 39% over the past year.모든 업데이트 보기Recent updatesReported Earnings • Feb 08Full year 2025 earnings released: EPS: CHF19.97 (vs CHF19.70 in FY 2024)Full year 2025 results: EPS: CHF19.97 (up from CHF19.70 in FY 2024). Revenue: CHF1.95b (down 6.7% from FY 2024). Net income: CHF467.0m (up 1.3% from FY 2024). Profit margin: 24% (up from 22% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 4% per year and the company’s share price has also fallen by 4% per year.공시 • Feb 05+ 1 more updateEMS-CHEMIE HOLDING AG to Report Fiscal Year 2025 Final Results on Jul 10, 2026EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2025 final results on Jul 10, 2026분석 기사 • Jan 14Estimating The Fair Value Of EMS-CHEMIE HOLDING AG (VTX:EMSN)Key Insights Using the 2 Stage Free Cash Flow to Equity, EMS-CHEMIE HOLDING fair value estimate is CHF601 EMS-CHEMIE...공시 • Jan 06EMS-CHEMIE HOLDING AG to Report Fiscal Year 2025 Results on Feb 06, 2026EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2025 results on Feb 06, 2026분석 기사 • Dec 27EMS-CHEMIE HOLDING AG's (VTX:EMSN) Share Price Could Signal Some RiskEMS-CHEMIE HOLDING AG's ( VTX:EMSN ) price-to-earnings (or "P/E") ratio of 27.6x might make it look like a sell right...분석 기사 • Nov 12Investors Met With Slowing Returns on Capital At EMS-CHEMIE HOLDING (VTX:EMSN)If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...분석 기사 • Oct 27Is EMS-CHEMIE HOLDING (VTX:EMSN) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Reported Earnings • Sep 01First half 2025 earnings released: EPS: CHF10.71 (vs CHF10.66 in 1H 2024)First half 2025 results: EPS: CHF10.71 (up from CHF10.66 in 1H 2024). Revenue: CHF1.02b (down 6.2% from 1H 2024). Net income: CHF250.4m (flat on 1H 2024). Profit margin: 25% (up from 23% in 1H 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 3% per year.Upcoming Dividend • Aug 05Upcoming dividend of CHF17.25 per shareEligible shareholders must have bought the stock before 12 August 2025. Payment date: 14 August 2025. Payout ratio is a comfortable 71% and the cash payout ratio is 90%. Trailing yield: 2.7%. Lower than top quartile of Swiss dividend payers (3.9%). In line with average of industry peers (2.8%).분석 기사 • Aug 05Calculating The Intrinsic Value Of EMS-CHEMIE HOLDING AG (VTX:EMSN)SWX:EMSN 1 Year Share Price vs Fair Value Explore EMS-CHEMIE HOLDING's Fair Values from the Community and select yours...분석 기사 • Jul 15EMS-CHEMIE HOLDING (VTX:EMSN) Is Increasing Its Dividend To CHF17.25EMS-CHEMIE HOLDING AG ( VTX:EMSN ) has announced that it will be increasing its dividend from last year's comparable...공시 • Jul 15EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 09, 2025EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 09, 2025, at 10:30 W. Europe Standard Time.Declared Dividend • Jul 14Dividend increased to CHF17.25Dividend of CHF17.25 is 7.8% higher than last year. Ex-date: 12th August 2025 Payment date: 14th August 2025 Dividend yield will be 2.7%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (71% earnings payout ratio) but not adequately covered by cash flows (90.1% cash payout ratio). The dividend has increased by an average of 3.7% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 13% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • Jul 13EMS-CHEMIE HOLDING AG announces Annual dividend, payable on August 14, 2025EMS-CHEMIE HOLDING AG announced Annual dividend of CHF 13.9500 per share payable on August 14, 2025, ex-date on August 12, 2025 and record date on August 13, 2025.분석 기사 • Jun 24EMS-CHEMIE HOLDING AG's (VTX:EMSN) Share Price Not Quite Adding UpEMS-CHEMIE HOLDING AG's ( VTX:EMSN ) price-to-earnings (or "P/E") ratio of 29.8x might make it look like a strong sell...공시 • Apr 01EMS-CHEMIE HOLDING AG to Report Fiscal Year 2024 Final Results on Jul 11, 2025EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2024 final results on Jul 11, 2025Reported Earnings • Mar 31Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: CHF19.70 (up from CHF19.56 in FY 2023). Revenue: CHF2.09b (down 5.5% from FY 2023). Net income: CHF460.8m (flat on FY 2023). Profit margin: 22% (up from 21% in FY 2023). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.6%. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 12% per year.Buy Or Sell Opportunity • Mar 10Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 7.2% to CHF677. The fair value is estimated to be CHF561, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 4.9% over the last 3 years. Earnings per share has declined by 7.8%. For the next 3 years, revenue is forecast to grow by 3.7% per annum. Earnings are also forecast to grow by 5.0% per annum over the same time period.공시 • Nov 27EMS-CHEMIE HOLDING AG to Report Fiscal Year 2024 Results on Feb 07, 2025EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2024 results on Feb 07, 2025공시 • Oct 23EMS-CHEMIE HOLDING AG to Report First Half, 2025 Results on Jul 11, 2025EMS-CHEMIE HOLDING AG announced that they will report first half, 2025 results on Jul 11, 2025Board Change • Sep 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman of the Board Bernhard Merki was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Sep 02First half 2024 earnings: EPS and revenues miss analyst expectationsFirst half 2024 results: EPS: CHF10.66 (up from CHF10.49 in 1H 2023). Revenue: CHF1.09b (down 8.1% from 1H 2023). Net income: CHF249.4m (up 1.6% from 1H 2023). Profit margin: 23% (up from 21% in 1H 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 2.6%. Earnings per share (EPS) also missed analyst estimates by 4.8%. Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 10% per year.Upcoming Dividend • Aug 06Upcoming dividend of CHF19.25 per shareEligible shareholders must have bought the stock before 13 August 2024. Payment date: 15 August 2024. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of Swiss dividend payers (4.4%). Higher than average of industry peers (1.7%).Price Target Changed • Jul 16Price target increased by 8.2% to CHF731Up from CHF675, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CHF708. Stock is up 2.6% over the past year. The company is forecast to post earnings per share of CHF20.29 for next year compared to CHF19.56 last year.Declared Dividend • Jul 15Dividend of CHF19.25 announcedShareholders will receive a dividend of CHF19.25. Ex-date: 13th August 2024 Payment date: 15th August 2024 Dividend yield will be 2.6%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is covered by both earnings (65% earnings payout ratio) and cash flows (71% cash payout ratio). The dividend has increased by an average of 3.8% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 24% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • Apr 03EMS-CHEMIE HOLDING AG to Report Fiscal Year 2023 Final Results on Jul 12, 2024EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2023 final results on Jul 12, 2024Reported Earnings • Mar 22Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: CHF19.71 (down from CHF22.75 in FY 2022). Revenue: CHF2.19b (down 12% from FY 2022). Net income: CHF461.0m (down 13% from FY 2022). Profit margin: 21% (in line with FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 6.8%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 11Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: CHF19.71 (down from CHF22.75 in FY 2022). Revenue: CHF2.19b (down 12% from FY 2022). Net income: CHF461.0m (down 13% from FY 2022). Profit margin: 21% (in line with FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 6.8%. Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.공시 • Jan 09EMS-CHEMIE HOLDING AG to Report Fiscal Year 2023 Results on Feb 09, 2024EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2023 results on Feb 09, 2024공시 • Oct 31EMS-CHEMIE HOLDING AG to Report First Half, 2024 Results on Jul 12, 2024EMS-CHEMIE HOLDING AG announced that they will report first half, 2024 results on Jul 12, 2024공시 • Oct 11EMS-CHEMIE HOLDING AG to Report Q3, 2023 Results on Oct 31, 2023EMS-CHEMIE HOLDING AG announced that they will report Q3, 2023 results on Oct 31, 2023Reported Earnings • Sep 01First half 2023 earnings released: EPS: CHF10.48 (vs CHF12.19 in 1H 2022)First half 2023 results: EPS: CHF10.48 (down from CHF12.19 in 1H 2022). Revenue: CHF1.18b (down 7.9% from 1H 2022). Net income: CHF245.0m (down 14% from 1H 2022). Profit margin: 21% (down from 22% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.공시 • Aug 31EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 10, 2024EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 10, 2024.Upcoming Dividend • Aug 08Upcoming dividend of CHF20.00 per share at 2.8% yieldEligible shareholders must have bought the stock before 15 August 2023. Payment date: 17 August 2023. Payout ratio is a comfortable 69% but the company is paying out more than the cash it is generating. Trailing yield: 2.8%. Lower than top quartile of Swiss dividend payers (4.1%). Lower than average of industry peers (4.0%).Reported Earnings • Mar 29Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: CHF22.87 (down from CHF23.53 in FY 2021). Revenue: CHF2.44b (up 7.0% from FY 2021). Net income: CHF535.0m (down 2.8% from FY 2021). Profit margin: 22% (down from 24% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) also surpassed analyst estimates by 1.8%. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 7% per year.Reported Earnings • Feb 13Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: CHF22.87 (down from CHF23.53 in FY 2021). Revenue: CHF2.44b (up 7.0% from FY 2021). Net income: CHF535.0m (down 2.8% from FY 2021). Profit margin: 22% (down from 24% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) also surpassed analyst estimates by 1.8%. Revenue is forecast to stay flat during the next 2 years compared to a 6.2% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 2% per year.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. Independent Non-Executive Director Christoph Mader was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Price Target Changed • Oct 31Price target decreased to CHF757Down from CHF849, the current price target is an average from 7 analysts. New target price is 20% above last closing price of CHF630. Stock is down 31% over the past year. The company is forecast to post earnings per share of CHF23.96 for next year compared to CHF23.53 last year.Buying Opportunity • Oct 27Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 13%. The fair value is estimated to be CHF830, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 3.1%. Revenue is forecast to grow by 6.8% in 2 years. Earnings is forecast to grow by 7.6% in the next 2 years.Price Target Changed • Oct 26Price target decreased to CHF826Down from CHF902, the current price target is an average from 7 analysts. New target price is 24% above last closing price of CHF665. Stock is down 29% over the past year. The company is forecast to post earnings per share of CHF24.02 for next year compared to CHF23.53 last year.공시 • Oct 18EMS-CHEMIE HOLDING AG to Report Q3, 2022 Results on Oct 25, 2022EMS-CHEMIE HOLDING AG announced that they will report Q3, 2022 results on Oct 25, 2022Reported Earnings • Sep 01First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFirst half 2022 results: EPS: CHF12.20 (up from CHF11.89 in 1H 2021). Revenue: CHF1.28b (up 10% from 1H 2021). Net income: CHF285.0m (up 2.5% from 1H 2021). Profit margin: 22% (down from 24% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.9%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 6.2%, compared to a 13% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has increased by 6% per year.공시 • Aug 26+ 1 more updateEMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 12, 2023EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 12, 2023.Upcoming Dividend • Aug 09Upcoming dividend of CHF21.00 per shareEligible shareholders must have bought the stock before 16 August 2022. Payment date: 18 August 2022. Payout ratio is a comfortable 70% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of Swiss dividend payers (4.0%). Higher than average of industry peers (1.8%).공시 • Jul 16EMS-CHEMIE HOLDING AG Proposes DividendEMS-CHEMIE HOLDING AG proposed a dividend payment of total CHF 21.00 (CHF 17.00) per share at the to be held ordinary annual general meeting held on August 13, 2022.Buying Opportunity • Jun 13Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 10.0%. The fair value is estimated to be CHF947, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to grow by 8.0% per annum. Earnings is also forecast to grow by 8.7% per annum over the same time period.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Christoph Maeder was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공시 • Apr 20EMS-CHEMIE HOLDING AG to Report Q1, 2022 Results on Apr 27, 2022EMS-CHEMIE HOLDING AG announced that they will report Q1, 2022 results on Apr 27, 2022Reported Earnings • Mar 28Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: CHF23.53 (up from CHF18.57 in FY 2020). Revenue: CHF2.28b (up 25% from FY 2020). Net income: CHF550.3m (up 27% from FY 2020). Profit margin: 24% (in line with FY 2020). Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 11%, compared to a 11% growth forecast for the industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.Reported Earnings • Feb 13Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: CHF23.64 (up from CHF18.57 in FY 2020). Revenue: CHF2.25b (up 23% from FY 2020). Net income: CHF553.0m (up 27% from FY 2020). Profit margin: 25% (in line with FY 2020). Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 10%, compared to a 9.4% growth forecast for the industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Buying Opportunity • Jan 24Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 3.1%. The fair value is estimated to be CHF1,149, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 7.2% per annum over the last 3 years. Earnings per share has declined by 4.1% per annum over the last 3 years.Board Change • Dec 06Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Christoph Maeder was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Sep 01First half 2021 earnings released: EPS CHF11.89 (vs CHF8.17 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: CHF1.17b (up 38% from 1H 2020). Net income: CHF278.0m (up 46% from 1H 2020). Profit margin: 24% (up from 23% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.Upcoming Dividend • Aug 03Upcoming dividend of CHF17.00 per shareEligible shareholders must have bought the stock before 10 August 2021. Payment date: 12 August 2021. Trailing yield: 1.7%. Lower than top quartile of Swiss dividend payers (3.5%). Higher than average of industry peers (1.2%).Price Target Changed • Jul 26Price target increased to CHF936Up from CHF844, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of CHF966. Stock is up 21% over the past year.Price Target Changed • Apr 24Price target increased to CHF801Up from CHF712, the current price target is an average from 5 analysts. New target price is 9.3% below last closing price of CHF883. Stock is up 39% over the past year.Reported Earnings • Mar 27Full year 2020 earnings released: EPS CHF18.57 (vs CHF22.54 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CHF1.83b (down 17% from FY 2019). Net income: CHF434.3m (down 18% from FY 2019). Profit margin: 24% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings.Is New 90 Day High Low • Feb 26New 90-day low: CHF805The company is down 2.0% from its price of CHF819 on 27 November 2020. The Swiss market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF585 per share.Analyst Estimate Surprise Post Earnings • Feb 17Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) also surpassed analyst estimates by 4.4%. Over the next year, revenue is forecast to grow 16%, compared to a 6.3% growth forecast for the Chemicals industry in Switzerland.Reported Earnings • Feb 14Full year 2020 earnings released: EPS CHF18.81 (vs CHF22.54 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CHF1.80b (down 18% from FY 2019). Net income: CHF440.0m (down 17% from FY 2019). Profit margin: 24% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings.이익 및 매출 성장 예측SWX:EMSN - 애널리스트 향후 추정치 및 과거 재무 데이터 (CHF Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20282,117541501569612/31/20272,032517482557712/31/20261,955488487544712/31/20251,969467506534N/A9/30/20251,996464476507N/A6/30/20252,024462445479N/A3/31/20252,057461446480N/A12/31/20242,091461448480N/A9/30/20242,104461473505N/A6/30/20242,117462499529N/A3/31/20242,165460513553N/A12/31/20232,213458527576N/A9/30/20232,294475456523N/A6/30/20232,374493385469N/A3/31/20232,425512328418N/A12/31/20222,475532272366N/A9/30/20222,438545297385N/A6/30/20222,401557322403N/A3/31/20222,342554380461N/A12/31/20212,283550438518N/A9/30/20212,218536443512N/A6/30/20212,154521447507N/A3/31/20211,994478435489N/A12/31/20201,833434423472N/A9/30/20201,867444443497N/A6/30/20201,900453462522N/A3/31/20202,055490476537N/A12/31/20192,209527489552N/A9/30/20192,257527N/A541N/A6/30/20192,305527N/A529N/A3/31/20192,327523N/A514N/A12/31/20182,350520N/A499N/A9/30/20182,330517N/A509N/A6/30/20182,310515N/A520N/A3/31/20182,243498N/A481N/A12/31/20172,177482N/A443N/A9/30/20172,126471N/A446N/A6/30/20172,076461N/A449N/A3/31/20172,044455N/A468N/A12/31/20162,012449N/A486N/A9/30/20161,987428N/A467N/A6/30/20161,962407N/A449N/A3/31/20161,947392N/A429N/A12/31/20151,932376N/A410N/A9/30/20151,944360N/A427N/A6/30/20151,956344N/A445N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: EMSN 의 연간 예상 수익 증가율(5%)이 saving rate(0.6%)보다 높습니다.수익 vs 시장: EMSN 의 연간 수익(5%)이 Swiss 시장(10.9%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: EMSN 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: EMSN 의 수익(연간 2.7%)이 Swiss 시장(연간 4.9%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: EMSN 의 수익(연간 2.7%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: EMSN의 자본 수익률은 3년 후 27.2%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/22 13:38종가2026/06/22 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스EMS-CHEMIE HOLDING AG는 14명의 분석가가 다루고 있습니다. 이 중 7명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Konstantin WiechertBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity ResearchAdrien TamagnoBerenberg11명의 분석가 더 보기
Price Target Changed • Jul 16Price target increased by 8.2% to CHF731Up from CHF675, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CHF708. Stock is up 2.6% over the past year. The company is forecast to post earnings per share of CHF20.29 for next year compared to CHF19.56 last year.
Price Target Changed • Oct 31Price target decreased to CHF757Down from CHF849, the current price target is an average from 7 analysts. New target price is 20% above last closing price of CHF630. Stock is down 31% over the past year. The company is forecast to post earnings per share of CHF23.96 for next year compared to CHF23.53 last year.
Price Target Changed • Oct 26Price target decreased to CHF826Down from CHF902, the current price target is an average from 7 analysts. New target price is 24% above last closing price of CHF665. Stock is down 29% over the past year. The company is forecast to post earnings per share of CHF24.02 for next year compared to CHF23.53 last year.
Price Target Changed • Jul 26Price target increased to CHF936Up from CHF844, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of CHF966. Stock is up 21% over the past year.
Price Target Changed • Apr 24Price target increased to CHF801Up from CHF712, the current price target is an average from 5 analysts. New target price is 9.3% below last closing price of CHF883. Stock is up 39% over the past year.
Reported Earnings • Feb 08Full year 2025 earnings released: EPS: CHF19.97 (vs CHF19.70 in FY 2024)Full year 2025 results: EPS: CHF19.97 (up from CHF19.70 in FY 2024). Revenue: CHF1.95b (down 6.7% from FY 2024). Net income: CHF467.0m (up 1.3% from FY 2024). Profit margin: 24% (up from 22% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 4% per year and the company’s share price has also fallen by 4% per year.
공시 • Feb 05+ 1 more updateEMS-CHEMIE HOLDING AG to Report Fiscal Year 2025 Final Results on Jul 10, 2026EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2025 final results on Jul 10, 2026
분석 기사 • Jan 14Estimating The Fair Value Of EMS-CHEMIE HOLDING AG (VTX:EMSN)Key Insights Using the 2 Stage Free Cash Flow to Equity, EMS-CHEMIE HOLDING fair value estimate is CHF601 EMS-CHEMIE...
공시 • Jan 06EMS-CHEMIE HOLDING AG to Report Fiscal Year 2025 Results on Feb 06, 2026EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2025 results on Feb 06, 2026
분석 기사 • Dec 27EMS-CHEMIE HOLDING AG's (VTX:EMSN) Share Price Could Signal Some RiskEMS-CHEMIE HOLDING AG's ( VTX:EMSN ) price-to-earnings (or "P/E") ratio of 27.6x might make it look like a sell right...
분석 기사 • Nov 12Investors Met With Slowing Returns on Capital At EMS-CHEMIE HOLDING (VTX:EMSN)If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
분석 기사 • Oct 27Is EMS-CHEMIE HOLDING (VTX:EMSN) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Reported Earnings • Sep 01First half 2025 earnings released: EPS: CHF10.71 (vs CHF10.66 in 1H 2024)First half 2025 results: EPS: CHF10.71 (up from CHF10.66 in 1H 2024). Revenue: CHF1.02b (down 6.2% from 1H 2024). Net income: CHF250.4m (flat on 1H 2024). Profit margin: 25% (up from 23% in 1H 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 3% per year.
Upcoming Dividend • Aug 05Upcoming dividend of CHF17.25 per shareEligible shareholders must have bought the stock before 12 August 2025. Payment date: 14 August 2025. Payout ratio is a comfortable 71% and the cash payout ratio is 90%. Trailing yield: 2.7%. Lower than top quartile of Swiss dividend payers (3.9%). In line with average of industry peers (2.8%).
분석 기사 • Aug 05Calculating The Intrinsic Value Of EMS-CHEMIE HOLDING AG (VTX:EMSN)SWX:EMSN 1 Year Share Price vs Fair Value Explore EMS-CHEMIE HOLDING's Fair Values from the Community and select yours...
분석 기사 • Jul 15EMS-CHEMIE HOLDING (VTX:EMSN) Is Increasing Its Dividend To CHF17.25EMS-CHEMIE HOLDING AG ( VTX:EMSN ) has announced that it will be increasing its dividend from last year's comparable...
공시 • Jul 15EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 09, 2025EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 09, 2025, at 10:30 W. Europe Standard Time.
Declared Dividend • Jul 14Dividend increased to CHF17.25Dividend of CHF17.25 is 7.8% higher than last year. Ex-date: 12th August 2025 Payment date: 14th August 2025 Dividend yield will be 2.7%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (71% earnings payout ratio) but not adequately covered by cash flows (90.1% cash payout ratio). The dividend has increased by an average of 3.7% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 13% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • Jul 13EMS-CHEMIE HOLDING AG announces Annual dividend, payable on August 14, 2025EMS-CHEMIE HOLDING AG announced Annual dividend of CHF 13.9500 per share payable on August 14, 2025, ex-date on August 12, 2025 and record date on August 13, 2025.
분석 기사 • Jun 24EMS-CHEMIE HOLDING AG's (VTX:EMSN) Share Price Not Quite Adding UpEMS-CHEMIE HOLDING AG's ( VTX:EMSN ) price-to-earnings (or "P/E") ratio of 29.8x might make it look like a strong sell...
공시 • Apr 01EMS-CHEMIE HOLDING AG to Report Fiscal Year 2024 Final Results on Jul 11, 2025EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2024 final results on Jul 11, 2025
Reported Earnings • Mar 31Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: CHF19.70 (up from CHF19.56 in FY 2023). Revenue: CHF2.09b (down 5.5% from FY 2023). Net income: CHF460.8m (flat on FY 2023). Profit margin: 22% (up from 21% in FY 2023). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.6%. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 12% per year.
Buy Or Sell Opportunity • Mar 10Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 7.2% to CHF677. The fair value is estimated to be CHF561, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 4.9% over the last 3 years. Earnings per share has declined by 7.8%. For the next 3 years, revenue is forecast to grow by 3.7% per annum. Earnings are also forecast to grow by 5.0% per annum over the same time period.
공시 • Nov 27EMS-CHEMIE HOLDING AG to Report Fiscal Year 2024 Results on Feb 07, 2025EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2024 results on Feb 07, 2025
공시 • Oct 23EMS-CHEMIE HOLDING AG to Report First Half, 2025 Results on Jul 11, 2025EMS-CHEMIE HOLDING AG announced that they will report first half, 2025 results on Jul 11, 2025
Board Change • Sep 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman of the Board Bernhard Merki was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Sep 02First half 2024 earnings: EPS and revenues miss analyst expectationsFirst half 2024 results: EPS: CHF10.66 (up from CHF10.49 in 1H 2023). Revenue: CHF1.09b (down 8.1% from 1H 2023). Net income: CHF249.4m (up 1.6% from 1H 2023). Profit margin: 23% (up from 21% in 1H 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 2.6%. Earnings per share (EPS) also missed analyst estimates by 4.8%. Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 10% per year.
Upcoming Dividend • Aug 06Upcoming dividend of CHF19.25 per shareEligible shareholders must have bought the stock before 13 August 2024. Payment date: 15 August 2024. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of Swiss dividend payers (4.4%). Higher than average of industry peers (1.7%).
Price Target Changed • Jul 16Price target increased by 8.2% to CHF731Up from CHF675, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CHF708. Stock is up 2.6% over the past year. The company is forecast to post earnings per share of CHF20.29 for next year compared to CHF19.56 last year.
Declared Dividend • Jul 15Dividend of CHF19.25 announcedShareholders will receive a dividend of CHF19.25. Ex-date: 13th August 2024 Payment date: 15th August 2024 Dividend yield will be 2.6%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is covered by both earnings (65% earnings payout ratio) and cash flows (71% cash payout ratio). The dividend has increased by an average of 3.8% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 24% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • Apr 03EMS-CHEMIE HOLDING AG to Report Fiscal Year 2023 Final Results on Jul 12, 2024EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2023 final results on Jul 12, 2024
Reported Earnings • Mar 22Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: CHF19.71 (down from CHF22.75 in FY 2022). Revenue: CHF2.19b (down 12% from FY 2022). Net income: CHF461.0m (down 13% from FY 2022). Profit margin: 21% (in line with FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 6.8%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 11Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: CHF19.71 (down from CHF22.75 in FY 2022). Revenue: CHF2.19b (down 12% from FY 2022). Net income: CHF461.0m (down 13% from FY 2022). Profit margin: 21% (in line with FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 6.8%. Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
공시 • Jan 09EMS-CHEMIE HOLDING AG to Report Fiscal Year 2023 Results on Feb 09, 2024EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2023 results on Feb 09, 2024
공시 • Oct 31EMS-CHEMIE HOLDING AG to Report First Half, 2024 Results on Jul 12, 2024EMS-CHEMIE HOLDING AG announced that they will report first half, 2024 results on Jul 12, 2024
공시 • Oct 11EMS-CHEMIE HOLDING AG to Report Q3, 2023 Results on Oct 31, 2023EMS-CHEMIE HOLDING AG announced that they will report Q3, 2023 results on Oct 31, 2023
Reported Earnings • Sep 01First half 2023 earnings released: EPS: CHF10.48 (vs CHF12.19 in 1H 2022)First half 2023 results: EPS: CHF10.48 (down from CHF12.19 in 1H 2022). Revenue: CHF1.18b (down 7.9% from 1H 2022). Net income: CHF245.0m (down 14% from 1H 2022). Profit margin: 21% (down from 22% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
공시 • Aug 31EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 10, 2024EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 10, 2024.
Upcoming Dividend • Aug 08Upcoming dividend of CHF20.00 per share at 2.8% yieldEligible shareholders must have bought the stock before 15 August 2023. Payment date: 17 August 2023. Payout ratio is a comfortable 69% but the company is paying out more than the cash it is generating. Trailing yield: 2.8%. Lower than top quartile of Swiss dividend payers (4.1%). Lower than average of industry peers (4.0%).
Reported Earnings • Mar 29Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: CHF22.87 (down from CHF23.53 in FY 2021). Revenue: CHF2.44b (up 7.0% from FY 2021). Net income: CHF535.0m (down 2.8% from FY 2021). Profit margin: 22% (down from 24% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) also surpassed analyst estimates by 1.8%. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 7% per year.
Reported Earnings • Feb 13Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: CHF22.87 (down from CHF23.53 in FY 2021). Revenue: CHF2.44b (up 7.0% from FY 2021). Net income: CHF535.0m (down 2.8% from FY 2021). Profit margin: 22% (down from 24% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) also surpassed analyst estimates by 1.8%. Revenue is forecast to stay flat during the next 2 years compared to a 6.2% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 2% per year.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. Independent Non-Executive Director Christoph Mader was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Price Target Changed • Oct 31Price target decreased to CHF757Down from CHF849, the current price target is an average from 7 analysts. New target price is 20% above last closing price of CHF630. Stock is down 31% over the past year. The company is forecast to post earnings per share of CHF23.96 for next year compared to CHF23.53 last year.
Buying Opportunity • Oct 27Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 13%. The fair value is estimated to be CHF830, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 3.1%. Revenue is forecast to grow by 6.8% in 2 years. Earnings is forecast to grow by 7.6% in the next 2 years.
Price Target Changed • Oct 26Price target decreased to CHF826Down from CHF902, the current price target is an average from 7 analysts. New target price is 24% above last closing price of CHF665. Stock is down 29% over the past year. The company is forecast to post earnings per share of CHF24.02 for next year compared to CHF23.53 last year.
공시 • Oct 18EMS-CHEMIE HOLDING AG to Report Q3, 2022 Results on Oct 25, 2022EMS-CHEMIE HOLDING AG announced that they will report Q3, 2022 results on Oct 25, 2022
Reported Earnings • Sep 01First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFirst half 2022 results: EPS: CHF12.20 (up from CHF11.89 in 1H 2021). Revenue: CHF1.28b (up 10% from 1H 2021). Net income: CHF285.0m (up 2.5% from 1H 2021). Profit margin: 22% (down from 24% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.9%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 6.2%, compared to a 13% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has increased by 6% per year.
공시 • Aug 26+ 1 more updateEMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 12, 2023EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 12, 2023.
Upcoming Dividend • Aug 09Upcoming dividend of CHF21.00 per shareEligible shareholders must have bought the stock before 16 August 2022. Payment date: 18 August 2022. Payout ratio is a comfortable 70% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of Swiss dividend payers (4.0%). Higher than average of industry peers (1.8%).
공시 • Jul 16EMS-CHEMIE HOLDING AG Proposes DividendEMS-CHEMIE HOLDING AG proposed a dividend payment of total CHF 21.00 (CHF 17.00) per share at the to be held ordinary annual general meeting held on August 13, 2022.
Buying Opportunity • Jun 13Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 10.0%. The fair value is estimated to be CHF947, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to grow by 8.0% per annum. Earnings is also forecast to grow by 8.7% per annum over the same time period.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Christoph Maeder was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공시 • Apr 20EMS-CHEMIE HOLDING AG to Report Q1, 2022 Results on Apr 27, 2022EMS-CHEMIE HOLDING AG announced that they will report Q1, 2022 results on Apr 27, 2022
Reported Earnings • Mar 28Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: CHF23.53 (up from CHF18.57 in FY 2020). Revenue: CHF2.28b (up 25% from FY 2020). Net income: CHF550.3m (up 27% from FY 2020). Profit margin: 24% (in line with FY 2020). Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 11%, compared to a 11% growth forecast for the industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
Reported Earnings • Feb 13Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: CHF23.64 (up from CHF18.57 in FY 2020). Revenue: CHF2.25b (up 23% from FY 2020). Net income: CHF553.0m (up 27% from FY 2020). Profit margin: 25% (in line with FY 2020). Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 10%, compared to a 9.4% growth forecast for the industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Buying Opportunity • Jan 24Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 3.1%. The fair value is estimated to be CHF1,149, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 7.2% per annum over the last 3 years. Earnings per share has declined by 4.1% per annum over the last 3 years.
Board Change • Dec 06Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Christoph Maeder was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Sep 01First half 2021 earnings released: EPS CHF11.89 (vs CHF8.17 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: CHF1.17b (up 38% from 1H 2020). Net income: CHF278.0m (up 46% from 1H 2020). Profit margin: 24% (up from 23% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
Upcoming Dividend • Aug 03Upcoming dividend of CHF17.00 per shareEligible shareholders must have bought the stock before 10 August 2021. Payment date: 12 August 2021. Trailing yield: 1.7%. Lower than top quartile of Swiss dividend payers (3.5%). Higher than average of industry peers (1.2%).
Price Target Changed • Jul 26Price target increased to CHF936Up from CHF844, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of CHF966. Stock is up 21% over the past year.
Price Target Changed • Apr 24Price target increased to CHF801Up from CHF712, the current price target is an average from 5 analysts. New target price is 9.3% below last closing price of CHF883. Stock is up 39% over the past year.
Reported Earnings • Mar 27Full year 2020 earnings released: EPS CHF18.57 (vs CHF22.54 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CHF1.83b (down 17% from FY 2019). Net income: CHF434.3m (down 18% from FY 2019). Profit margin: 24% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings.
Is New 90 Day High Low • Feb 26New 90-day low: CHF805The company is down 2.0% from its price of CHF819 on 27 November 2020. The Swiss market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF585 per share.
Analyst Estimate Surprise Post Earnings • Feb 17Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) also surpassed analyst estimates by 4.4%. Over the next year, revenue is forecast to grow 16%, compared to a 6.3% growth forecast for the Chemicals industry in Switzerland.
Reported Earnings • Feb 14Full year 2020 earnings released: EPS CHF18.81 (vs CHF22.54 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CHF1.80b (down 18% from FY 2019). Net income: CHF440.0m (down 17% from FY 2019). Profit margin: 24% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings.